Sales Droop for Breast Implants & Botox
February 06, 2009
Breasts! They're back! Say goodbye to insanely inflated neck-choking plumpers and get used to the real thing. On Wednesday, Allergan, the makers of Botox and breast implants, reported the company's quarterly overall sales down 3% from last year. While Allergan does most of its business in eyecare (they recently discovered their glaucoma drug also helps create longer "wolf eyes" lashes), vanity products saw a significant sales drop from the same time last year. Botox fell 3%, skin-plumping injections withered almost 9%, and breast implants collapsed 12%.
“Wrinkled faces may be the latest example of recession chic,” reports the New York Times. A poll among dermatologists and plastic surgeons revealed procedures are down 20% to 50%. Meanwhile, Allergan’s prexy is doing his part to keep spirits buoyant, encouraging consumers with $50 Botox coupons and $100 rebates for Juvederm facial fillers. D-cups are still going to cost you a stack of C-notes, though.
Comments (1)
Post a Comment
Anonymous comments are moderated. To comment instantly, register with BlackBook. Click here to login.


Posted by Rohin Guha on Fri Feb 6, 2009 at 01.05 pm
That picture is spectacular.